连续灌流培养杂交瘤细胞生产单克隆抗体

自 2 0世纪 70年代以来 ,工程抗体在基础医学研究、临床诊断和治疗 ,以及免疫预防等领域中的广泛应用 ,大大促进了其产业化的进程。目前工业化生产单克隆抗体的主要方法是通过发酵罐、中空纤维和固定床等生物反应器培养系统 ,以微载体、微包囊法在体外大规模高密度培养杂交瘤细胞 ,再通过相关的纯化手段浓缩纯化制备抗体[1 ,2 ] 。就操作方式而言 ,一般采用两个基本策略 :①大容量高密度的悬浮培养 ,最多采用的是搅拌式气升式生物反应器 ,通过微载体依托细胞相对固定化 ,降低了搅拌培养时对细胞的剪切力 ,提高细胞的密度和稳定性及生产率。…     

DMSO抑制杂交瘤增殖促进抗体的分泌

利用DMSO促进杂交瘤细胞分泌单克隆抗体,并对其作用机制进行了研究。结果表明在杂交瘤细胞对数生长后期添加0.6%浓度的DMSO与对照相比可提高抗体的产量2倍;流式细胞仪检测细胞周期表明此时837%的细胞处于G1期;免疫印记结果显示在有DMSO作用下杂交瘤细胞P27 蛋白表达显著升高。因此,DMSO 可通过促进P27蛋白的表达,抑制杂交瘤细胞的增殖,从而提高杂交瘤细胞分泌抗体的能力。对DMSO进一步在高密度大规模培养杂交瘤细胞中的应用具有重要意义。     

小鼠杂交瘤细胞在双口滚动培养瓶中的生长及抗体分泌

研制了一种新的滚动式细胞培养装置(rolling culture system)和双口滚动瓶(double-mouthed roller).利用分泌抗人绒毛膜促性腺激素(hCG)单克隆抗体的小鼠杂交瘤细胞作为检验材料,对培养在双口滚动培养装置及常规T形瓶中的细胞生长和单抗分泌进行了比较.在滚动培养装置中(转速2～10 r/min)培养的细胞生长和抗体分泌皆增加30%以上.不同浓度的血清对细胞生长和抗体产量有一定影响,含5%血清的培养液中生长的杂交瘤细胞单抗产量最高;添加少量明胶可增加细胞生长和抗体产量.     

Basic Studies for Continuous Production of L-Aspartic Acid by Immobilized Escherichia coli Cells

By using a column packed with immobilized Escherichia coli cells entrapped in a polyacrylamide gel lattice, conditions for continuous production of L-aspartic acid from ammonium fumarate were investigated. When a solution of 1 M ammonium fumarate (pH 8.5) containing 1 mM Mg(2+) was passed through the immobilized cell column at a flow rate of space velocity (SV) = 0.8 at 37 C, the highest rate of reaction was attained. From the column effluents, L-aspartic acid was obtained in good yield. The immobilized cell column was very stable.     

The Effect of Space Flight on Monoclonal Antibody Synthesis in a Hybridoma Mouse Cell Line

The hybridoma cell line, 3G10G5, producing a monoclonal antibody to the major capsid protein VP1 from the avian polyomavirus budgerigar fledgling disease virus, was produced from a Balb/C mouse. This cell line was used to test the effects of microgravity on cellular processes, specifically protein synthesis. A time course study utilizing incorporation of [³⁵S]methionine into newly synthesized monoclonal antibody was performed on STS-77. After 5.5 days, it was observed that cell counts for the samples exposed to microgravity were lower than those of ground-based samples. However, radiolabel incorporation of the synthesized monoclonal antibody was similar in both orbiter and ground control samples. Overall, microgravity does not seem to have an effect on this cell line's ability to synthesize IgG protein.     

High Yield of Human Monoclonal Antibody Produced by Stably Transfected Drosophila Schneider 2 Cells in Perfusion Culture Using Wave Bioreactor

Since it was first introduced in late 1990s Wave bioreactor has been used for protein production by mammalian and insect cell lines. However, using Wave bioreactor to produce human monoclonal antibody by stable Drosophila Schneider 2 (S2) cell transfectants has not been reported before. In this study, S2 cells were co-transfected with an inducible vector expressing human monoclonal antibody heavy and light chains, respectively, specific for hemagglutinin (HA) of H5N1 influenza virus. Stable S2 transfectant clone was selected by limiting dilution assay. Stable S2 transfectant clone that produce the highest amount of human monoclonal antibody was inoculated into two 2-l disposable cellbags, where cell growth and antibody production were compared between batch and perfusion cultures using Wave bioreactor. Here, we report that maximum viable cell density reached 1.06?×?10(7) cells/ml in batch culture; whereas 1.04?×?10(8)?cells/ml was achieved in perfusion culture. The maximum volumetric antibody productivity in batch culture was 52?mg/l/day; while perfusion culture yielded 1,437?mg/l/day. As a result, the total antibody production was 201?mg in batch culture and 8,212?mg in perfusion culture. The antibody produced by both cultures displays full neutralizing activity. Thus, our results provide strong support for using Wave bioreactor in perfusion culture for a large-scale production of human monoclonal antibody by stable S2 cell transfectants.     

固定化生长酵母连续生产酒精的研究中间试验报告

造粒器与柱式生物反应器成—封闭系统,采用正交试验确定的最适固定化条件,以海藻酸钙凝胶法进行细胞固定化,连续造粒,在反应器中完成固定化。固定化酵母在反应器中通气培养20小时左右,凝胶球细胞数达2×10~9/me,其增长速度比传统工艺自然细胞快10倍。固定化生长细胞用于生物反应器连续发酵甜菜糖蜜酒精,酒精生产能力为22.1—23.67g/L凝胶球/小时,为传统工艺酒精生产能力的10倍。停留时间为3小时。反应器系统由两个0.7KL柱式反应器和1个0.8KL成熟醪接收器组成。发酵周期由传统工艺的20小时左右,缩短为4小时,酒精含量为8.5—9.0％(V/V),对1.2号反应器的动态变化及其在发酵中的作用进行了系统研究,糖蜜中可发酵糖75％的转化是在1号反应器中完成的。     

Characterization of a Monoclonal Antibody Cell Culture Production Process Using a Quality by Design Approach

The goal of quality by design (QbD) in cell culture manufacturing is to develop manufacturing processes which deliver products with consistent critical quality attributes (CQAs). QbD approaches can lead to better process understanding through the use of process parameter risk ranking and statistical design of experiments (DOE). The QbD process starts with an analysis of process parameter risk with respect to CQAs and key performance indicators (KPIs). Initial DOE study designs and their factor test ranges are based on the outcomes of the process parameter risk ranking exercises. Initial DOE studies screen factors for significant influences on CQAs as well as characterize responses for process KPIs. In the case study provided here, multifactor process characterization studies using a scale-down model resulted in significant variation in charge heterogeneity of a monoclonal antibody (MAb) as measured by ion-exchange chromatography (IEC). Iterative DOE studies, using both screening and response surface designs, were used to narrow the operating parameter ranges so that charge heterogeneity could be controlled to an acceptable level. The data from the DOE studies were used to predict worst-case conditions, which were then verified by testing at those conditions. Using the approach described here, multivariate process parameter ranges were identified that yield acceptable CQA levels and that still provide operational flexibility for manufacturing.     

固定化细胞的混合糖连续发酵动力学模型

利用固定化啤酒酵母和固定化毕赤酵母在两个串联的固定床内连续发酵由葡萄糖和木糖组成的混合糖制取酒精的过程,建立了连续发酵的非结构动力学模型。该模型以带抑制项的米氏动力学方程为酶动力学基础,考虑了抑制物抑制、底物抑制、轴向弥散及膜传质等因素。成功地引入了一个综合考虑颗粒相内外传质的总有效因子简化模型的计算,并取得了较为满意的仿真结果。     

Production of L-Phenylacetyl Carbinol by Immobilized Cells of Saccharomyces Cerevisiae

Conversion of benzaldehyde to L-phenylacetyl carbinol (L-PAC) was achieved with immobilized, growing cells of Saccharomyces cerevisiae in different reactors. Product formation increased (31%) with the subsequent initial reuses of the entrapped cells. Biomass production and PAC formation depleted (40 and 57%, respectively) after 4-5 continuous growth and biotransformation cycles. With the regeneration of the biocatalysts, catalytic activity of the cells was resumed. The highest yields were in a stirred tank reactor (29 g PAC) from 77 g benzeldehyde with 14 repeated uses of entrapped cells.     

Semicontinuous and Continuous Production of Chloroperoxidase by Caldariomyces fumago Immobilized in k-Carrageenan

Three strains of Caldariomyces fumago were immobilized in 4% k-carrageenan and tested for semicontinuous production of chloroperoxidase (CPO). Over an 80-day period, growing in defined medium, C. fumago strains CMI 89362 and ATCC 11925 produced enzyme concentrations of 99 and 71 mg/liter, respectively, during six production periods of 12 to 14 days, while C. fumago DAOM 137632 produced only 24 mg of CPO per liter during six growth periods of 10 days. CPO production was unaffected by various regimens of washing between transfers. Mycelial growth was primarily restricted to the head surface, and bead size increased linearly with time. Attempts to restrict growth but maintain CPO production were unsuccessful. Pigment production, fructose utilization, and pH change in the immobilized cell cultures compared closely with the growth characteristics of free cell cultures. By using an airlift tower fermentor with an external loop run with continuous medium replacement of 20 ml/h (D = 0.016), strain CMI 89362 in bead form produced CPO at 40 mg/liter for 11 days.     

OAS1蛋白单克隆抗体的制备及其表征

目的:用OAS1蛋白免疫小鼠,获得OAS1特异性单克隆抗体,为OAS1的含量测定提供基础。方法:通过全基因合成的方法获得目的基因序列,转化大肠杆菌BL21细胞诱导His-OAS1及OAS1蛋白表达,纯化后用作抗原免疫小鼠,取脾融合,筛选稳定分泌抗体的阳性细胞株,制备并纯化单抗,通过SDS-PAGE,ELISA,Western blot等方法进行检测。结果:体外高效表达OAS1蛋白,并成功制备特异性单克隆抗体,效价在5×10^-11mol/L以上,亲和常数为3.37×10⁸ L·mol^-1。结论:获得高亲和力OAS1单克隆抗体,为其含量的检测奠定了基础。     

体细胞基因打靶制备动物乳腺生物反应器的策略与应用

在转基因动物研究中,由于基因表达调控元件的人工拼接和外源基因在动物基因组中随机整合所带来的“位置效应”,致使转基因动物外源基因的表达水平不高并且差异较大。为此,利用定位整合优势,对以基因同源重组为基础的基因打靶技术进行了大量研究。介绍了就利用体细胞基因打靶和核移植技术制备动物乳腺生物反应器的策略和应用情况做一综述,并对提高基因打靶效率的各种策略,打靶细胞的选择,转基因细胞核移植的低融合事件以及基因打靶制备乳腺生物反应器的优越性进行分析。     

单克隆抗体制备的细胞工程学研究进展

单克隆抗体是近年来发展最快、最成功的大分子药物之一,哺乳动物细胞作为单抗大规模制备最适宜的宿主,在工业生产中仍然存在成本高、产率低等缺点。近年来,抗细胞凋亡、控制细胞周期、优化代谢过程等细胞工程学方面的研究极大地推动了抗体表达及翻译后修饰技术的发展。以下对近年来单克隆抗体制备在细胞工程学方面取得的进展作一综述,并探讨该领域未来可能的研究方向。     

工程原核生物和酵母菌中生产单克隆抗体和抗体片段研究进展 *

抗体药物和抗体片段药物在药物市场占据了重要的地位,主要通过哺乳动物细胞系统进行生产,操作复杂并且成本高。为了能够克服哺乳动物细胞系统生产抗体药物的弊端,越来越多的抗体及抗体片段在原核细胞及酵母菌中生产,但是产率往往不高并且没有糖基化。从基因转录和翻译的优化、分子伴侣的共表达和抑制蛋白水解降解等方面概述了在原核生物表达系统及酵母菌中提高单克隆抗体和抗体片段产量的研究进展,为未来利用原核生物和酵母菌实现工业化生产单克隆抗体及抗体片段奠定基础。     

利用固定化细胞连续发酵生产酸牛奶

本文报道了利用固定化技术连续发酵生产酸牛奶的方法。对单菌种与双菌种固定化、最适发酵温度和pH、发酵时间、固定化方式等进行了研究,得出了在实验室条件下,连续发酵生产酸牛奶的最佳技术条件。与传统的间歇生产工艺相比,可简化菌种制备过程,反复利用乳酸菌种,充分利用发酵酸化设备、便于自动化控制等优点。作者尚未见国内外利用固定化技术连续生产酸牛奶的报道。